News from f2g A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

22 Oct, 2020, 08:30 BST F2G Receives Second US FDA Breakthrough Therapy Designation for Olorofim

F2G Ltd, a UK- and Austria-based biotech company developing novel therapies for life-threatening systemic fungal infections, announced today that the ...


12 Aug, 2020, 08:00 BST F2G Closes US$60.8 Million Financing to fund late stage development of novel mechanism antifungal agent

F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, announced today that it has...


09 Mar, 2020, 09:00 GMT F2G Receives US FDA Orphan Drug Designation for Olorofim

F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, announced today that the U.S....


08 Apr, 2019, 09:17 BST F2G Appoints Dr. Patrick Vink as Chairman

F2G Ltd, the European biotech company developing novel therapies for life-threatening fungal infections, today announces the appointment of Dr....


07 Jan, 2019, 08:52 GMT F2G Expands Investor Syndicate and Progresses Phase 2b Study for Novel Antifungal

New investor Morningside Venture joins existing blue-chip investor syndicate Company accelerates global phase 2b study of lead candidate olorofim to...